col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Informa UK (Taylor & Francis): Human Vaccines & Immunotherapeutics
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―30 COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety Katherine Kricorian, Rachel Civen, Ozlem Equils
2 [GO] 2021―Jul―29 COVID-19 vaccination in Chinese children: a cross-sectional study on the cognition, psychological anxiety state and the willingness toward vaccination Jin Yang, Ting Zhang, Weiran Qi, Xingxing Zhang, Mengmeng Jia, Zhiwei Leng, et al. (+6)
3 [GO] 2021―Jul―29 Acceptability of COVID-19 vaccine in the working-age population in Shanghai city: a cross-sectional study Linlin Wu, Zhuoying Huang, Xiang Guo, Jiechen Liu, Xiaodong Sun
4 [GO] 2021―Jul―29 Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers Ahmet Soysal, Erdem Gönüllü, Nalan Karabayır, Servet Alan, Serkan Atıcı, İsmail Yıldız, et al. (+3)
5 [GO] 2021―Jul―26 The relationship of Covid-19 vaccine attitude with life satisfaction, religious attitude and Covid-19 avoidance in Turkey Mahmut Kilic, Nursel Ustundag Ocal, Gullu Uslukilic
6 [GO] 2021―Jul―22 Intention to get vaccinated against COVID-19 among the general population in France: Associated factors and gender disparities Caroline Alleaume, Pierre Verger, Fadia Dib, Jeremy K. Ward, Odile Launay, Patrick Peretti-Watel
7 [GO] 2021―Jul―22 COVID-19 vaccination passport: prospects, scientific feasibility, and ethical concerns Khan Sharun, Ruchi Tiwari, Kuldeep Dhama, Ali A. Rabaan, Saad Alhumaid
8 [GO] 2021―Jul―21 COVID-19 vaccination intention and influencing factors among different occupational risk groups: a cross-sectional study Tianyu Jiang, Xudong Zhou, Hanqian Wang, Shixin Dong, Menmen Wang, Hailati Akezhuoli, Hui Zhu
9 [GO] 2021―Jul―20 Early approval of COVID-19 vaccines: Pros and cons Md Arifur Rahman, Md Sayeedul Islam
10 [GO] 2021―Jul―19 Participating in a vaccine trial for COVID-19 in Senegal: trust and information V. Ridde, M. F. Ba, I. Gaye, A. I. Diallo, E. Bonnet, A. Faye
11 [GO] 2021―Jul―15 Expanded principles of ethics and its implementation during COVID-19 vaccine trials: A scoping evidence based research synthesis Vaibhav Kumar, Venetia Aranha, Rajni Rajgarhia, Abhishek Royal, Kedar Mehta
12 [GO] 2021―Jul―13 Changes in general practitioners’ attitudes toward COVID-19 vaccination after first interim results: a longitudinal approach in France Pierre Verger, Dimitri Scronias
13 [GO] 2021―Jul―13 Assessing licensed nurses COVID-19 vaccine attitudes and intentions: a cross-sectional survey in the state of Hawaii Holly B. Fontenot, Deborah Mattheus, Eunjung Lim, Alexandra Michel, Nicole Ryan, Katherine Finn Davis, Gregory Zimet
14 [GO] 2021―Jul―13 Landscape and progress of global COVID-19 vaccine development Hui-Yao Huang, Shu-Hang Wang, Yu Tang, Wei Sheng, Chi-Jian Zuo, Da-Wei Wu, et al. (+3)
15 [GO] 2021―Jul―09 Attitudes of school teachers toward influenza and COVID-19 vaccine in Greece during the COVID-19 pandemic Despoina Gkentzi, Eleni Benetatou, Ageliki Karatza, Aimilia Kanellopoulou, Sotirios Fouzas, Maria Lagadinou, et al. (+2)
16 [GO] 2021―Jul―09 Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York Tamar A. Smith-Norowitz, Jonathan I. Silverberg, Esther M. Norowitz, Stephan Kohlhoff, Margaret R Hammerschlag
17 [GO] 2021―Jul―09 The demand for a COVID-19 vaccine in Kenya Carlos E. Carpio, Oscar Sarasty, Darren Hudson, Anthony Macharia, Mumina Shibia
18 [GO] 2021―Jul―09 SARS-CoV-2 vaccination in the context of original antigenic sin Marek Petráš, Ivana Králová Lesná
19 [GO] 2021―Jul―08 COVID-19 vaccination attitudes and intention among Qers during the first and second waves of the pandemic: findings from repeated cross-sectional surveys Ève Dubé, Maude Dionne, Catherine Pelletier, Denis Hamel, Souleymane Gadio
20 [GO] 2021―Jul―08 Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey Saeed Mastour Alshahrani, Salem Dehom, Diaa Almutairi, Badr Saud Alnasser, Bandar Alsaif, Ahmed A. Alabdrabalnabi, et al. (+6)
21 [GO] 2021―Jul―08 Factors influencing COVID-19 vaccine hesitancy and acceptance among the Pakistani population Farooq Ahmad Chaudhary, Basaruddin Ahmad, Muhammad Danial Khalid, Ayesha Fazal, Muhammad Mohsin Javaid, Danial Qasim Butt
22 [GO] 2021―Jul―06 Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants Zhuoming Liu, Hua Wu, Kristi A. Egland, Theron C. Gilliland, Matthew D. Dunn, Thomas C. Luke, et al. (+4)
23 [GO] 2021―Jul―06 COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa Andrea C. Carcelen, Christine Prosperi, Simon Mutembo, Gershom Chongwe, Francis D. Mwansa, Phillimon Ndubani, et al. (+10)
24 [GO] 2021―Jul―02 Gender differences in the determinants of willingness to get the COVID-19 vaccine among the working-age population in Japan Tomohiro Ishimaru, Makoto Okawara, Hajime Ando, Ayako Hino, Tomohisa Nagata, Seiichiro Tateishi, et al. (+3)
25 [GO] 2021―Jul―01 Subacute thyroiditis following COVID-19 vaccination in a 67-year-old male patient: a case report Melisa Şahin Tekin, Suzan Şaylısoy, Göknur Yorulmaz
26 [GO] 2021―Jul―01 Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance Silvana A. M. Urru, Evelina Maines, Annalisa Campomori, Massimo Soffiati
27 [GO] 2021―Jun―30 COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic Kuldeep Dhama, Khan Sharun, Ruchi Tiwari, Manish Dhawan, Talha Bin Emran, Ali A. Rabaan, Saad Alhumaid
28 [GO] 2021―Jun―30 A qualitative study exploring the relationship between mothers’ vaccine hesitancy and health beliefs with COVID-19 vaccination intention and prevention during the early pandemic months Kimberly K. Walker, Katharine J. Head, Heather Owens, Gregory D. Zimet
29 [GO] 2021―Jun―29 Is ‘original antigenic sin’ complicating indian vaccination drive against Covid-19? Vipin M. Vashishtha
30 [GO] 2021―Jun―25 Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management Oriana Simonetti, Giulia Radi, Elisa Molinelli, Giulio Rizzetto, Federico Diotallevi, Annamaria Offidani
31 [GO] 2021―Jun―25 Likelihood of COVID-19 vaccination by subgroups across the US: post-election trends and disparities Peter G. Szilagyi, Kyla Thomas, Megha D. Shah, Nathalie Vizueta, Yan Cui, Sitaram Vangala, Arie Kapteyn
32 [GO] 2021―Jun―25 Extended theory of planned behavior in explaining the intention to COVID-19 vaccination uptake among mainland Chinese university students: an online survey study Chia-Wei Fan, I-Hua Chen, Nai-Ying Ko, Cheng-Fang Yen, Chung-Ying Lin, Mark D. Griffiths, Amir H. Pakpour
33 [GO] 2021―Jun―25 COVID-19 vaccine development from the perspective of cancer patients Yang He, Yi Ding, Bo Cao, Yi Huang, Xiao Wang
34 [GO] 2021―Jun―25 Vaccine certificate during domestic traveling: a potential initiative to prevent COVID-19 waves in India Om Prakash Choudhary, Indraj Singh
35 [GO] 2021―Jun―23 Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies Khan Sharun, Ruchi Tiwari, Kuldeep Dhama, Talha Bin Emran, Ali A. Rabaan, Abbas Al Mutair
36 [GO] 2021―Jun―18 Attitudes of health care professionals towards COVID-19 vaccine - a sequence from Turkey Muhammet Ali Oruç, Onur Öztürk
37 [GO] 2021―Jun―17 Parental acceptability of COVID-19 vaccination for children under the age of 18 years among Chinese doctors and nurses: a cross-sectional online survey Zixin Wang, Rui She, Xi Chen, Liping Li, Lijuan Li, Zepeng Huang, Joseph T. F. Lau
38 [GO] 2021―Jun―15 Expanding the boundaries of vaccine discourse: impact of visual illustrations communication intervention on intention towards COVID-19 vaccination among victims of insecurity in Nigeria Joel C. Ugwuoke, Felix Olajide Talabi, Omowale Adelabu, Bernice O. Sanusi, Verlumun Celestine Gever, Chijioke Onuora
39 [GO] 2021―Jun―15 A case control study to assess effectiveness of measles containing vaccines in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children Nilesh Gujar, Muralidhar Tambe, Malangori Parande, Nandkumar Salunke, Ganesh Jagdale, Sarah G. Anderson, et al. (+3)
40 [GO] 2021―Jun―11 Temporary vaccination clinic for COVID-19 in Zhuhai, China Hao Jin, Jing Chu, Wei Zhao, Qiao Ye, Meixiao Zhan, Xiaoling Han, et al. (+4)
41 [GO] 2021―Jun―11 Are people previously infected with SARS-CoV-2 likely to experience COVID-19 symptoms again after vaccination? Results from an Italian COVID-19 referral center Marta Colaneri, Alice Di Benedetto, Lea Nadia Marvulli, Federica Bocchio, Sara Cutti, Carlo Marena, et al. (+2)
42 [GO] 2021―Jun―11 A rational strategy to support approved COVID-19 vaccines prioritization Javier Burgos-Salcedo
43 [GO] 2021―Jun―11 The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2 Wael Alturaiki, Ayman Mubarak, Abduallah Al Jurayyan, Maged Gomaa Hemida
44 [GO] 2021―Jun―07 Covid-19 pandemic: an opportunity to seize to increase awareness and vaccine coverage in at-risk populations Paul Loubet, Albert Sotto
45 [GO] 2021―Jun―07 COVID-19 vaccine hesitancy: a survey in a population highly compliant to common vaccinations Flora Fedele, Massimo Aria, Valeria Esposito, Maria Micillo, Gaetano Cecere, Maria Spano, Giulio De Marco
46 [GO] 2021―Jun―04 The influencing factors of discrimination against recovered Coronavirus disease 2019 (COVID-19) patients in China: a national study Rugang Liu, Stephen Nicholas, Anli Leng, Dongfu Qian, Elizabeth Maitland, Jian Wang
47 [GO] 2021―Jun―03 Intent to get vaccinated against COVID-19 among reproductive-aged women in Texas Abbey B. Berenson, Mihyun Chang, Jacqueline M. Hirth, Manasa Kanukurthy
48 [GO] 2021―May―29 Online study of health professionals about their vaccination attitudes and behavior in the COVID-19 era: addressing participation bias Pierre Verger, Dimitri Scronias, Yves Fradier, Malika Meziani, Bruno Ventelou
49 [GO] 2021―May―29 Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs Geert Byttebier, Luc Belmans, Myriam Alexander, Bo E. H. Saxberg, Bart De Spiegeleer, Anton De Spiegeleer, et al. (+6)
50 [GO] 2021―May―29 Are the new SARS-CoV-2 variants resistant against the vaccine? Mohnad Abdalla, Amr Ahmed El-Arabey, Xinyi Jiang
51 [GO] 2021―May―28 Knowledge, attitude, and practice toward COVID-19 vaccination in Kazakhstan: a cross-sectional study Alpamys Issanov, Zylkiya Akhmetzhanova, Dieter Riethmacher, Mohamad Aljofan
52 [GO] 2021―May―25 COVID-19 vaccine platforms: Delivering on a promise? Mark Verdecia, John F. Kokai-Kun, Maura Kibbey, Sarita Acharya, Jaap Venema, Fouad Atouf
53 [GO] 2021―May―25 Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2 Char Leung
54 [GO] 2021―May―25 Reactive arthritis after COVID-19 vaccination Qi-jun An, De-an Qin, Jin-xian Pei
55 [GO] 2021―May―21 Evaluation of COVID-19 vaccine acceptance of healthcare providers in a tertiary Pediatric hospital Metin Yigit, Aslinur Ozkaya-Parlakay, Emrah Senel
56 [GO] 2021―May―20 Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient Masoud Etemadifar, Amirhossein Akhavan Sigari, Nahad Sedaghat, Mehri Salari, Hosein Nouri
57 [GO] 2021―May―20 COVID-19 vaccine delay: An examination of United States residents’ intention to delay vaccine uptake Carl Latkin, Lauren Dayton, Grace Yi, Afareen Jaleel, Chikaodinaka Nwosu, Rupali Limaye
58 [GO] 2021―May―20 Exploring perception and hesitancy toward COVID-19 vaccine: A study from Jordan Rana K. Abu Farha, Karem H. Alzoubi, Omar F. Khabour, Mahmoud A. Alfaqih
59 [GO] 2021―May―20 Alteration in vaccination rates and an evaluation of physicians’ perceptions of the possible impact of the SARS-CoV-2 pandemic on childhood vaccinations in Ankara, Turkey Ateş Kara, Sare İlbay, Osman Topaç, Elif Ayla Arabulan, Hasan Tezer, Nilüfer Tavukçu, Çiğdem Şimşek
60 [GO] 2021―May―19 Covid-19 vaccine, acceptance, and concern of safety from public perspective in the state of Odisha, India Dibya Sundar Panda, Ranjan Kumar Giri, Anil Kumar Nagarajappa, Sakeenabi Basha
61 [GO] 2021―May―19 “This choice does not just affect me.” Attitudes of pregnant women toward COVID-19 vaccines: a mixed-methods study Sarah Geoghegan, Laura C. Stephens, Kristen A. Feemster, Richard J. Drew, Maeve Eogan, Karina M. Butler
62 [GO] 2021―May―17 Effect of vaccine effectiveness and safety on COVID-19 vaccine acceptance in Detroit, Michigan, July 2020 Abram L. Wagner, Sherri Sheinfeld Gorin, Matthew L. Boulton, Brian A. Glover, Jeffrey D. Morenoff
63 [GO] 2021―May―14 Acceptance of a COVID-19 vaccine and associated factors among pregnant women in China: a multi-center cross-sectional study based on health belief model Liyuan Tao, Ruitong Wang, Na Han, Jihong Liu, Chuanxiang Yuan, Lixia Deng, et al. (+4)
64 [GO] 2021―May―12 Perspectives on the use and risk of adverse events associated with cytokine-storm targeting antibodies and challenges associated with development of novel monoclonal antibodies for the treatment of COVID-19 clinical cases Aishwarya Mary Johnson, Robert Barigye, Hariharan Saminathan
65 [GO] 2021―May―11 Changes in legislator vaccine-engagement on Twitter before and after the arrival of the COVID-19 pandemic Eden Engel-Rebitzer, Daniel Camargo Stokes, Alison Buttenheim, Jonathan Purtle, Zachary F. Meisel
66 [GO] 2021―May―06 Is a single COVID-19 vaccine dose enough in convalescents ? Daniele Focosi, Andreina Baj, Fabrizio Maggi
67 [GO] 2021―May―06 Experimental studies using OMV in a new platform do SARS-CoV-2 vaccines Emanuelle B. Gaspar, Carlos Roberto Prudencio, Elizabeth De Gaspari
68 [GO] 2021―May―05 Pattern of vaccination delivery around COVID-19 lockdown in Nigeria Ryoko Sato
69 [GO] 2021―May―02 Parents’ willingness to pay for a COVID-19 vaccine for themselves and their children in the United States Serkan Catma, Diana Reindl
70 [GO] 2021―Apr―29 Impact of influenza vaccination on the risk of SARS-CoV-2 infection in a middle-aged group of people Andrzej Bozek, Renata Kozłowska, Beata Galuszka, Alicja Grzanka
71 [GO] 2021―Apr―23 The COVID-19 vaccine social media infodemic: healthcare providers’ missed dose in addressing misinformation and vaccine hesitancy Raquel G. Hernandez, Loni Hagen, Kimberly Walker, Heather O’Leary, Cecile Lengacher
72 [GO] 2021―Apr―22 Safety survey by clinical pharmacists on COVID-19 vaccination from a single center in China Guangfei Wang, Lin Zhu, Yiqing Zhu, Qiaofeng Ye, Xin Yu, Meng Fu, et al. (+9)
73 [GO] 2021―Apr―21 Prevalence and associated factors of intention of COVID-19 vaccination among healthcare workers in China: application of the Health Belief Model Yanqiu Yu, Joseph T. F. Lau, Rui She, Xi Chen, Liping Li, Lijuan Li, Xiaojun Chen
74 [GO] 2021―Apr―17 Demand and motivation for influenza vaccination among healthcare workers before and during the COVID-19 era: a cross-sectional survey Ladislav Štěpánek, Marie Nakládalová, Helena Vildová, Alena Boriková, Magdaléna Janošíková, Kateřina Ivanová
75 [GO] 2021―Apr―17 Pediatricians’ COVID-19 experiences and views on the willingness to receive COVID-19 vaccines: a cross-sectional survey in Turkey Erdem Gönüllü, Ahmet Soysal, Serkan Atıcı, Mesut Engin, Osman Yeşilbaş, Tuba Kasap, et al. (+11)
76 [GO] 2021―Apr―17 Countries with high deaths due to flu and tuberculosis demonstrate lower COVID-19 mortality: roles of vaccinations Sanmoy Pathak, Mohit Kumar Jolly, Dipankar Nandi
77 [GO] 2021―Apr―15 Willingness to receive SARS-CoV-2 vaccine among healthcare workers in public institutions of Zhejiang Province, China Jing Wang, Yaling Feng, Zhigang Hou, Yuzhong Lu, Huihong Chen, Le Ouyang, et al. (+9)
78 [GO] 2021―Apr―14 SARS-CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice Jeroen Pollet, Wen-Hsiang Chen, Leroy Versteeg, Brian Keegan, Bin Zhan, Junfei Wei, et al. (+14)
79 [GO] 2021―Apr―08 Positive aspects of the mRNA platform for SARS-CoV-2 vaccines Khalid Hajissa, Ali Mussa
80 [GO] 2021―Mar―26 BCG vaccination potential for COVID-19: an analytical approach Mina T. Kelleni
81 [GO] 2021―Mar―25 Digital tools, multidisciplinarity and innovation for communicating vaccine safety in the COVID-19 era Francesco Gesualdo, Lucie M. Bucci, Caterina Rizzo, Alberto E. Tozzi
82 [GO] 2021―Mar―25 A global pandemic in the time of viral memes: COVID-19 vaccine misinformation and disinformation on TikTok Corey H. Basch, Zoe Meleo-Erwin, Joseph Fera, Christie Jaime, Charles E. Basch
83 [GO] 2021―Mar―24 Factors associated with the willingness and acceptance of SARS-CoV-2 vaccine from adult subjects in China Di Liu, Lan Luo, Fangfei Xie, Zengli Yu, Zheng Feei Ma, Yun Wang, Zhongxiao Wan
84 [GO] 2021―Mar―23 A comparative online survey on the intention to get COVID-19 vaccine between Greek and Cypriot healthcare personnel: is the country a predictor? Vasilios Raftopoulos, Stelios Iordanou, Angeliki Katsapi, Xanthi Dedoukou, Helena C. Maltezou
85 [GO] 2021―Mar―15 Epidemiology of coronaviruses, genetics, vaccines, and scenario of current pandemic of coronavirus diseases 2019 (COVID-19): a fuzzy set approach Fazal Mehmood Khan, Tauseef Ahmad, Muhammad Gulistan, Wathek Chammam, Muhammad Khan, Jin Hui
86 [GO] 2021―Mar―15 Impact of COVID-19 pandemic on vaccination coverage among children aged 15 to 23 months at Dessie town, Northeast Ethiopia, 2020 Debrnesh Goshiye Miretu, Zinet Abegaz Asfaw, Sisay Gedamu Addis
87 [GO] 2021―Mar―12 Nigerian media coverage of medical progress on the development of COVID-19 vaccine Chika Euphemia Asogwa
88 [GO] 2021―Mar―09 Research trends in COVID-19 vaccine: a bibliometric analysis Tauseef Ahmad, Manal Abdulaziz Murad, Mukhtiar Baig, Jin Hui
89 [GO] 2021―Mar―08 Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future? Charles Shey Wiysonge, Duduzile Ndwandwe, Jill Ryan, Anelisa Jaca, Oumarou Batouré, Blanche-Philomene Melanga Anya, Sara Cooper
90 [GO] 2021―Mar―02 β-glucans: wide-spectrum immune-balancing food-supplement-based enteric (β-WIFE) vaccine adjuvant approach to COVID-19 Nobunao Ikewaki, Masaru Iwasaki, Gene Kurosawa, Kosagi-Sharaf Rao, Johant Lakey-Beitia, Senthilkumar Preethy, Samuel JK Abraham
91 [GO] 2021―Feb―24 Online mis/disinformation and vaccine hesitancy in the era of COVID-19: Why we need an eHealth literacy revolution Fadia Dib, Philippe Mayaud, Pierre Chauvin, Odile Launay
92 [GO] 2021―Feb―20 Phylodynamic analysis in the understanding of the current COVID-19 pandemic and its utility in vaccine and antiviral design and assessment Jaime A. Cardona-Ospina, Diana M. Rojas-Gallardo, Sandra C. Garzón-Castaño, Erika V. Jiménez-Posada, Alfonso J. Rodríguez-Morales
93 [GO] 2021―Feb―20 A study on willingness and influencing factors to receive COVID-19 vaccination among Qingdao residents Feng Yang, Xiaofan Li, Xiaoting Su, Tingting Xiao, Yang Wang, Ping Hu, et al. (+5)
94 [GO] 2021―Feb―19 Willingness of the general population to accept and pay for COVID-19 vaccination during the early stages of COVID-19 pandemic: a nationally representative survey in mainland China Yutong Zhang, Xiaoqin Luo, Zheng Feei Ma
95 [GO] 2021―Feb―12 Impact of the coronavirus disease 2019 epidemic and a free influenza vaccine strategy on the willingness of residents to receive influenza vaccines in Shanghai, China Yehong Zhou, Jing Tang, Junjie Zhang, Qiangsong Wu
96 [GO] 2021―Feb―07 Coronavirus (SARS-CoV-2): a systematic review for potential vaccines Mihir Bhatta, Srijita Nandi, Shanta Dutta, Malay Kumar Saha
97 [GO] 2021―Feb―05 Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany Daniela Marín-Hernández, Douglas F. Nixon, Nathaniel Hupert
98 [GO] 2021―Feb―01 An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination Musha Chen, Yanjun Li, Jiaoshan Chen, Ziyu Wen, Fengling Feng, Huachun Zou, et al. (+4)
99 [GO] 2021―Jan―23 The measles outbreak in Israel in 2018-19: lessons for COVID-19 pandemic Chen Stein-Zamir, Hagai Levine
100 [GO] 2021―Jan―15 Pneumococcal carriage in children with COVID-19 Kubra Aykac, Yasemin Ozsurekci, Burcu Ceylan Cura Yayla, Kubra Evren, Sibel Lacinel Gurlevik, Pembe Derin Oygar, et al. (+5)
101 [GO] 2021―Jan―04 Special focus ‘SARS-CoV-2 / COVID-19: advances in developing vaccines and immunotherapeutics’ Kuldeep Dhama, Yashpal Singh Malik, Ali A. Rabaan, Alfonso J. Rodriguez-Morales
102 [GO] 2021―Jan―04 SARS-CoV-2 reinfection and implications for vaccine development Firzan Nainu, Rufika Shari Abidin, Muh. Akbar Bahar, Andri Frediansyah, Talha Bin Emran, Ali A Rabaan, et al. (+2)
103 [GO] 2020―Dec―30 The association of previous influenza vaccination and coronavirus disease-2019 Ilan Green, Shai Ashkenazi, Eugene Merzon, Shlomo Vinker, Avivit Golan-Cohen
104 [GO] 2020―Dec―17 Politicizing public health: the powder keg of rushing COVID-19 vaccines Rupali J. Limaye, Molly Sauer, Shaun A. Truelove
105 [GO] 2020―Dec―10 Exploring the possible use of saponin adjuvants in COVID-19 vaccine Rinku Sharma, Arivukarasu Palanisamy, Kuldeep Dhama, Gorakh Mal, Birbal Singh, Karam Pal Singh
106 [GO] 2020―Dec―03 COVID-19 in the elderly people and advances in vaccination approaches Kuldeep Dhama, Shailesh Kumar Patel, Senthilkumar Natesan, Kranti Suresh Vora, Mohd Iqbal Yatoo, Ruchi Tiwari, et al. (+4)
107 [GO] 2020―Dec―03 Plant-based vaccines and antibodies to combat COVID-19: current status and prospects Kuldeep Dhama, Senthilkumar Natesan, Mohd. Iqbal Yatoo, Shailesh Kumar Patel, Ruchi Tiwari, Shailendra K Saxena, Harapan Harapan
108 [GO] 2020―Dec―03 Vaccine safety - is the SARS-CoV-2 vaccine any different? Noam Tau, Dafna Yahav, Daniel Shepshelovich
109 [GO] 2020―Dec―03 Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward Vipin M. Vashishtha, Puneet Kumar
110 [GO] 2020―Nov―27 COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey Susan M. Sherman, Louise E. Smith, Julius Sim, Richard Amlôt, Megan Cutts, Hannah Dasch, et al. (+2)
111 [GO] 2020―Nov―24 Recombinant vaccines for COVID-19 Tushar Yadav, Nishant Srivastava, Gourav Mishra, Kuldeep Dhama, Swatantra Kumar, Bipin Puri, Shailendra K Saxena
112 [GO] 2020―Nov―24 Factors associated with parents’ willingness to enroll their children in trials for COVID-19 vaccination Ran D. Goldman, Georg Staubli, Cristina Parra Cotanda, Julie C. Brown, Julia Hoeffe, Michelle Seiler, et al. (+13)
113 [GO] 2020―Nov―22 Knowledge, attitudes, and practices towards influenza among Chinese adults during the epidemic of COVID-19: a cross-sectional online survey Minghuan Jiang, Liuxin Feng, Weihua Wang, Yilin Gong, Wai-Kit Ming, Khezar Hayat, et al. (+4)
114 [GO] 2020―Nov―13 Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19 Pouria Mosaddeghi, Farbod Shahabinezhad, Mohammadreza Dorvash, Mojtaba Goodarzi, Manica Negahdaripour
115 [GO] 2020―Nov―12 Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave? Laura Sticchi, Lucia Taramasso, Antonio Di Biagio, Dario Olobardi, Giancarlo Icardi, Matteo Bassetti
116 [GO] 2020―Nov―11 COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations Yina Cun, Chuanyin Li, Lei Shi, Ming Sun, Shuying Dai, Le Sun, et al. (+2)
117 [GO] 2020―Nov―11 Impact of COVID-19 on women and children and the need for a gendered approach in vaccine development Kranti Suresh Vora, Aarthi Sundararajan, Shahin Saiyed, Kuldeep Dhama, Senthilkumar Natesan
118 [GO] 2020―Nov―06 Recent advances in vaccine and immunotherapy for COVID-19 Ali A. Rabaan, Shamsah H. Al-Ahmed, Ranjit Sah, Jaffar. A. Al-Tawfiq, Ayman M. Al-Qaaneh, Lamiaa H. Al-Jamea, et al. (+8)
119 [GO] 2020―Nov―03 Who should be prioritised for COVID-19 vaccination? Fiona M Russell, Brian Greenwood
120 [GO] 2020―Oct―30 Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic Sukhadeo Baliram Barbuddhe, Deepak Bhiwa Rawool, Pankaj Prakash Gaonkar, Jess Vergis, Kuldeep Dhama, Satyaveer Singh Malik
121 [GO] 2020―Oct―30 The estimated impact of decreased childhood vaccination due to COVID-19 using a dynamic transmission model of mumps in Japan Taito Kitano, Hirosato Aoki
122 [GO] 2020―Oct―30 SARS-CoV-2 vaccine candidates in rapid development Lifeng Li, Pengbo Guo, Xiaoman Zhang, Zhidan Yu, Wancun Zhang, Huiqing Sun
123 [GO] 2020―Oct―29 Assessing COVID-19 vaccine literacy: a preliminary online survey Luigi Roberto Biasio, Guglielmo Bonaccorsi, Chiara Lorini, Sergio Pecorelli
124 [GO] 2020―Oct―20 Proposed clinical indicators for efficient screening and testing for COVID-19 infection using Classification and Regression Trees (CART) analysis Richard K. Zimmerman, Mary Patricia Nowalk, Todd Bear, Rachel Taber, Karen S. Clarke, Theresa M. Sax, et al. (+3)
125 [GO] 2020―Oct―20 Tocilizumab prescribing criteria for COVID-19 patients Ayman M. Al-Qaaneh, Fuad H. Al-Ghamdi
126 [GO] 2020―Oct―20 The Missing Link in the Covid-19 Vaccine Race John Zizzo
127 [GO] 2020―Oct―16 The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization Caitlyn Kellogg, Ozlem Equils
128 [GO] 2020―Oct―16 Evidence and speculations: vaccines and therapeutic options for COVID-19 pandemic Rabeea Siddique, Qian Bai, Muhammad Adnan Shereen, Ghulam Nabi, Guang Han, Farooq Rashid, et al. (+4)
129 [GO] 2020―Sep―30 COVID-19 vaccine development during pandemic: gap analysis, opportunities, and impact on future emerging infectious disease development strategies Shyam Rele
130 [GO] 2020―Sep―29 COVID-19 outbreak: a potential threat to routine vaccination programme activities in Nigeria Olorunfemi Akinbode Ogundele, Ayodeji Andrew Omotoso, Aderonke Tolulope Fagbemi
131 [GO] 2020―Sep―29 BCG vaccine: a hope to control COVID-19 pandemic amid crisis Yashpal Singh Malik, Mohd Ikram Ansari, Balasubramanian Ganesh, Shubhankar Sircar, Sudipta Bhat, Tripti Pande, et al. (+9)
132 [GO] 2020―Sep―29 Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia Harapan Harapan, Abram L. Wagner, Amanda Yufika, Wira Winardi, Samsul Anwar, Alex Kurniawan Gan, et al. (+8)
133 [GO] 2020―Sep―29 Considerations on the clinical development of COVID-19 vaccine from trial design perspectives Zhiwei Jiang, Xuanyi Wang, Jielai Xia
134 [GO] 2020―Sep―29 Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain Ping-Han Huang, Hsiao-Han Tsai, Bo-Hung Liao, Yi-Ling Lin, Jia-Tsrong Jan, Mi-Hua Tao, et al. (+3)
135 [GO] 2020―Sep―23 Preparatory phase for clinical trials of COVID-19 vaccine in Nepal Govind Prasad Gupta, Yogendra Shah, Dhan Kumar Pant, Sunil Lekhak, Ramesh Shahi, Ananda Mandal, et al. (+4)
136 [GO] 2020―Sep―23 COVID-19: benefits and risks of passive immunotherapeutics Ankur Gupta, Rashmi Karki, Himanshu R Dandu, Kuldeep Dhama, Madan LB Bhatt, Shailendra K Saxena
137 [GO] 2020―Sep―22 Contemplating HPV vaccination in Japan during the time of COVID-19 Ai Miyoshi, Yutaka Ueda, Tadashi Kimura
138 [GO] 2020―Sep―22 Impact of COVID-19 on vaccination programs: adverse or positive? Inayat Ali
139 [GO] 2020―Sep―22 Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Chao Zhang, Chenliang Zhou, Li Shi, Ge Liu
140 [GO] 2020―Sep―16 Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges Idris Nasir Abdullahi, Anthony Uchenna Emeribe, Hafeez Aderinsayo Adekola, Sharafudeen Dahiru Abubakar, Amos Dangana, Halima Ali Shuwa, et al. (+17)
141 [GO] 2020―Sep―15 Prospects for mucosal vaccine: shutting the door on SARS-CoV-2 Rajat Mudgal, Sanketkumar Nehul, Shailly Tomar
142 [GO] 2020―Sep―11 Coronavirus disease 2019 (COVID-19) in domestic animals and wildlife: advances and prospects in the development of animal models for vaccine and therapeutic research Khan Sharun, Ruchi Tiwari, Shailesh Kumar Patel, Kumaragurubaran Karthik, Mohd Iqbal Yatoo, Yashpal S. Malik, et al. (+5)
143 [GO] 2020―Sep―03 Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19 Jaffar A. Al-Tawfiq, Yaseen Arabi
144 [GO] 2020―Sep―03 Intravescical instillation of Calmette-Guérin bacillus and COVID-19 risk Ugo Fedeli, Angelo Porreca, Michele Colicchia, Elena Schievano, Walter Artibani, Luigi Roberto Biasio, Giorgio Palé
145 [GO] 2020―Sep―03 Current perspective on diagnosis, epidemiological assessment, prevention strategies, and potential therapeutic interventions for severe acute respiratory infections caused by 2019 novel coronavirus (SARS-CoV-2) Komal Rizwan, Tahir Rasheed, Shakeel Ahmad Khan, Muhammad Bilal, Tahir Mahmood
146 [GO] 2020―Sep―03 Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses Patrick O’Connell, Yasser A. Aldhamen
147 [GO] 2020―Aug―26 Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19 Kumaragurubaran Karthik, Tuticorin Maragatham Alagesan Senthilkumar, Shanmugasundaram Udhayavel, Gopal Dhinakar Raj
148 [GO] 2020―Aug―26 Vaccines and routine immunization strategies during the COVID-19 pandemic Ener Cagri Dinleyici, Ray Borrow, Marco Aurélio Palazzi Safadi, Pierre van Damme, Flor M. Munoz
149 [GO] 2020―Aug―26 Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2 Muhammad Bilal, Hafiz M. N. Iqbal
150 [GO] 2020―Aug―25 Cytokines and COVID-19: friends or foes? Mohsen Rokni, Michael R Hamblin, Nima Rezaei
151 [GO] 2020―Aug―12 Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2 Mohamad Hesam Shahrajabian, Wenli Sun, Qi Cheng
152 [GO] 2020―Aug―08 Are BCG-induced non-specific effects adequate to provide protection against COVID-19? Vipin M. Vashishtha
153 [GO] 2020―Aug―05 Coronavirus disease 2019-Historical context, virology, pathogenesis, immunotherapy, and vaccine development Sayeh Ezzikouri, Jalal Nourlil, Soumaya Benjelloun, Michinori Kohara, Kyoko Tsukiyama-Kohara
154 [GO] 2020―Jul―31 The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay Li Ping Wong, Haridah Alias, Pooi-Fong Wong, Hai Yen Lee, Sazaly AbuBakar
155 [GO] 2020―Jul―31 Seasonal influenza vaccination during a pandemic Heather Richmond, Natasha Rees, Sharon McHale, Aaron Rak, Jonathan Anderson
156 [GO] 2020―Jul―23 COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines Mohd. Iqbal Yatoo, Zeenat Hamid, Oveas Rafiq Parray, Aasim Habib Wani, Abrar Ul Haq, Archana Saxena, et al. (+8)
157 [GO] 2020―Jul―23 YouTube coverage of COVID-19 vaccine development: implications for awareness and uptake Corey H. Basch, Grace C. Hillyer, Emily A. Zagnit, Charles E. Basch
158 [GO] 2020―Jul―23 Promise and challenges in the development of COVID-19 vaccines Wangxue Chen
159 [GO] 2020―Jul―21 COVID-19 - Important considerations for developing and using a vaccine Inayat Ur Rahman, Niaz Ali, Farhana Ijaz, Aftab Afzal, Elsayed Fathi Abd_Allah
160 [GO] 2020―Jul―21 Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases Neha Puri, Eric A. Coomes, Hourmazd Haghbayan, Keith Gunaratne
161 [GO] 2020―Jul―17 Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development Samuel A. Cohen, Caitlyn Kellogg, Ozlem Equils
162 [GO] 2020―Jul―14 An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein Abdolkarim Sheikhi, Mohammad Hojjat-Farsangi
163 [GO] 2020―Jul―09 Thinking more about therapy with convalescent plasma for COVID-19 patients Guangshu Han, Yi-Hua Zhou
164 [GO] 2020―Jun―05 Novel Coronavirus disease 2019 (COVID-19): new challenges and new responsibilities in developing countries Faisal Rasheed Anjum, Sidra Anam, Sajjad Ur Rahman
165 [GO] 2020―May―21 COVID-19 pandemic; prevention, treatment, and mental health Suliman Khan, Rabeea Siddique, Zhe Li, Mengzhou Xue, Jianbo Liu, Ghulam Nabi
166 [GO] 2020―May―14 The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses Isidoro Feliciello, Alfredo Procino
167 [GO] 2020―Apr―16 Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19 Wen-Hsiang Chen, Peter J. Hotez, Maria Elena Bottazzi
168 [GO] 2020―Mar―18 COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics Kuldeep Dhama, Khan Sharun, Ruchi Tiwari, Maryam Dadar, Yashpal Singh Malik, Karam Pal Singh, Wanpen Chaicumpa
169 [GO] 2020―Mar―18 One Health approach and Coronavirus Disease 2019 Tauseef Ahmad, Jin Hui
170 [GO] 2020―Feb―12 Are we ready for the new fatal Coronavirus: scenario of Pakistan? Tauseef Ahmad, Muhammad Khan, Fazal Mehmood Khan, Jin Hui

[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.006 sec